APOE and hemophilia: Therefore, we tested the efficacy of both AAV2-LiA and AAV2-LiC in hemophilia B mice (BALB/c-F9−/Y) injected at a dose of 1 × 1011 vg with ssAAV-ApoE-hAAT-hF9 vector.